Adis Journals
Browse
Summary Slide.png (64.04 kB)

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK

Download (64.04 kB)
figure
posted on 2020-04-16, 08:49 authored by Pierre Johansen, Barrie Chubb, Barnaby Hunt, Samuel J. P. Malkin, Anna Sandberg, Matthew Capehorn

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    Cost-effectivenessDiabetesEconomic evaluationGlucagon-like peptide-1 receptor agonistsLiraglutideSemaglutideType 2 diabetes

    Licence

    CC BY-NC 4.0

    Exports